Skip to content

Virginia · Nonprofit

FRIEDREICH'S ATAXIA RESEARCH ALLIANCE

FRIEDREICH'S ATAXIA RESEARCH ALLIANCE (Virginia) receives grants from 126 organizations whose IRS filings report $31,555,763 to it, the largest being THE CHRISTINA FOUNDATION ($17,461,084). 66 of them have funded it in more than one year.

Revenue FY2024
$13M
Funders on record
126
Grants received
$32M
Net assets
$6.3M
66/126 repeat funderspeak grant-dependency 66%
01What it does

What Friedreich's Ataxia Research Alliance does

Mission

To marshal and focus the resources and relationships needed to cure fa by raising funds for research, promoting public awareness and aligning scientists, patients, clinicians, government agencies and pharmaceutical companies dedicated to curing fa and related disorders.

As stated on its FY2024 Form 990.

Programs

  1. Research and grant program - see schedule o

    $10,330,478 spentof which $9,606,747 as grants
    82% of program spending
  2. Clinical research infrastructurein addition to research grants, fara funds the ongoing development of domain resources in the form of vital clinical research infrastructure. Clinical research infrastructure refers to the resources needed to facilitate any type of research, including clinical trials that involve patients. These resources include programs like: friedreich's ataxia global patient registry: the friedreich's ataxia global patient registry (fagpr) is the only worldwide registry of friedreich's ataxia patients. The goals of the fagpr are to collect information on all fa patients in one registry, to develop the registry into a powerful resource for research, and to engage the fa community in studies aimed at advancing our knowledge (continued in schedule o)clinical research infrastructure (cont'd):of fa and the treatments being developed. Fara partners with international patient advocacy organizations through a governance board to ensure multi-stakeholder engagement and oversight of the fagpr. More than 1000 individuals with fa are enrolled and fagpr was used to recruit for several clinical trials and many clinical research studies. To learn more, visit…

    $1,354,745 spentof which $781,063 as grants
    11% of program spending
  3. Awareness, education, and outreach programs:awareness: friedreich ataxia (fa) is a rare disease; affecting 1 in 50,000 individuals. Fara is dedicated to advocacy and raising awareness for fa. Fara has utilized both traditional and social media strategies to bring greater awareness to fa in the general public and to engage and educate the fa community. For example, fara conducts an annual a social media campaign that encourages community participation leading up to fa awareness day. Advocacy: fara and the national ataxia foundation (naf) partnered on several advocacy initiatives relevant to the ataxia community. Mostly notably, the efforts of the two organizations resulted in the continued inclusion of hereditary ataxia as part of (continued in schedule o)advocacy: (cont'd)the congressionally directed medical research program (cdmrp) at the department of defense in fiscal year (fy) 24, resulting in four hereditary ataxia research grants being recommended for funding totaling over $12 million. Fara and naf were also successful in getting a resolution passed declaring september 25, 2024 national ataxia awareness day and hosting the sixth united against ataxia hill day- with 94…

    $491,179 spentof which $80,000 as grants
    4% of program spending
  4. Workshops, symposia, & conferencesinternational congress for ataxia researchin november 2024, the international congress for ataxia research (icar) brought together over 600 researchers from around the world. It was the largest icar to date and a powerful example of how we accelerate progress when experts across different types of ataxia come together to share ideas and collaborate. Fara was honored to co-host the meeting along with ataxia uk, national ataxia foundation, and the ataxia global initiative.this year's program included a mix of plenary sessions, breakout workshops, and scientific debate. The debate sparked thoughtful discussion about the strengths of in vivo vs. In vitro research models and highlighted how both approaches help to move the science forward.some insights and learnings from icar 2024 included: 1. Discovering that frataxin activity can be boosted by targeting other components of the iron-sulfur cluster assembly reveals a potential new treatment pathway. 2. Some gaa repeat interruptions are more common than previously known, impacting carrier detection and opening new therapeutic opportunities. 3. Inflammation might contribute to nerve damage in fa.…

    $357,617 spent
    3% of program spending

The 4 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $12,534,019.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($7.5M) Expenses 100 ($6.8M) Net assets 100 ($4.5M)2018 Revenue 101 ($7.6M) Expenses 103 ($7.0M) Net assets 110 ($5.0M)2019 Revenue 94 ($7.1M) Expenses 110 ($7.5M) Net assets 84 ($3.8M)2020 Revenue 167 ($13M) Expenses 114 ($7.7M) Net assets 192 ($8.7M)2021 Revenue 102 ($7.7M) Expenses 134 ($9.1M) Net assets 159 ($7.2M)2022 Revenue 147 ($11M) Expenses 163 ($11M) Net assets 151 ($6.8M)2023 Revenue 149 ($11M) Expenses 179 ($12M) Net assets 136 ($6.1M)2024 Revenue 174 ($13M) Expenses 195 ($13M) Net assets 138 ($6.3M)
'17'18'19'20'21'22'23'24
Revenue (174)Expenses (195)Net assets (138)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2019 to 2020, from $4.2M to $9.3M (+122%).

$4.9M
$5.1M
$4.2M
$9.3M
$7.5M
$7.3M
$7.8M
$6.9M
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2020 1% · 2021 3%. Grants only. Government contracts and fees sit inside program revenue.

103% of FRIEDREICH'S ATAXIA RESEARCH ALLIANCE’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).

This organization
Typical peer · 4,745 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 5 of the last 8 reported years ran a deficit.

$722k
’17
$554k
’18
−$405k
’19
$4.8M
’20
−$1.4M
’21
−$90k
’22
−$998k
’23
−$142k
’24
3.6
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Jennifer M Farmer

Chief executive officer

Board chair

Paul Avery

Chairman/ director

As listed on its FY2024 Form 990.

'17'18'19'20'21'22'23'24
Listed2019181821212223
Joined·+1+0+1+4+0+1+2
No longer listed·2111001
03Who funds it

Who funds it, year by year

2017 → 2023: the base broadened from 22 funders to 43 funders, grant income rose $1.6M → $4.2M.

32 of 126 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 14% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of FRIEDREICH'S ATAXIA RESEARCH ALLIANCE’s funders (the co-funder graph). Top 30 of 126 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

FRIEDREICH'S ATAXIA RESEARCH ALLIANCE leans on a few funders — its largest provides 55% of grant income and the top three 81%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

38% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund FRIEDREICH'S ATAXIA RESEARCH ALLIANCE.

55%
largest funder
81%
top three
~3
effective funders

Largest funder’s share by year: 2017 78% · 2018 77% · 2019 63% · 2020 89% · 2021 63% · 2022 54% · 2023 77% — broadly stable.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

34% of FRIEDREICH'S ATAXIA RESEARCH ALLIANCE's funders are still giving 3 years after their first grant; 52% give in more than one year at all.

first grant+1y+2y+3y+4y+5y+6y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

FRIEDREICH'S ATAXIA RESEARCH ALLIANCE draws 100% of its grant income from funders outside Virginia, across 23 states in all.

WA
ID
MN
IL
WI
MI
NY
MA
IN
PA
NJ
CT
RI
CA
MO
MD
DE
TN
NC
OK
AL
TX
FL

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
Virginia out of state home

Funder states come from each funder’s own filing. $4.3M arriving through sponsors registered in 22 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

FRIEDREICH'S ATAXIA RESEARCH ALLIANCE is better cushioned than half of the 4,580 health nonprofits its size.

Operating margin−1% · below the median
Months of reserve3.6mo · above the median
Revenue growth (annualized)8% · above the median

this organization peer median middle 50% of peers· 4,580 health nonprofits $10M–$100M, FY2024

Organizations like FRIEDREICH'S ATAXIA RESEARCH ALLIANCE

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Virginia

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

94% of spending goes to programs.

Program 94%Management 3%Fundraising 3%

Governance

19
board members
89%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

70%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 37 states

AK
ME
NH
WA
ND
MN
IL
WI
MI
NY
MA
OR
OH
PA
NJ
CT
RI
CA
UT
CO
MO
KY
WV
VA
MD
AZ
NM
KS
AR
TN
NC
SC
OK
MS
AL
GA
FL

Part of a family of 1 related entity

  • Stichting Friedreich's Ataxia Research Alliance Europe · exempt

Screen this organization

A dated, signed PDF of the compliance screen for FRIEDREICH'S ATAXIA RESEARCH ALLIANCE: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds FRIEDREICH'S ATAXIA RESEARCH ALLIANCE?
FRIEDREICH'S ATAXIA RESEARCH ALLIANCE (Virginia) receives grants from 126 organizations whose IRS filings report $31,555,763 to it, the largest being THE CHRISTINA FOUNDATION ($17,461,084). 66 of them have funded it in more than one year.
How many funders does FRIEDREICH'S ATAXIA RESEARCH ALLIANCE have?
IRS filings report 126 organizations giving $31,555,763 in grants to FRIEDREICH'S ATAXIA RESEARCH ALLIANCE, 66 of which have funded it in more than one year.
Who is the largest funder of FRIEDREICH'S ATAXIA RESEARCH ALLIANCE?
THE CHRISTINA FOUNDATION is the largest funder on record, with $17,461,084 in grants. The full list of funders is on this page.
How can an organization like FRIEDREICH'S ATAXIA RESEARCH ALLIANCE find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Virginia. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 126 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing